How Kedalion Therapeutics Positioned Breakthrough Ocular Technology for Acquisition
Kedalion Therapeutics developed a pioneering ophthalmic drug delivery platform designed to improve dosing precision, patient comfort, and treatment outcomes for front-of-eye therapies.
As the company advanced its AcuStream™ technology and prepared for commercialization, Howbridge partnered with leadership to strengthen positioning, clarify the market opportunity, and build a scalable communications platform capable of supporting fundraising, strategic partnerships, and long-term growth.
Ultimately, Kedalion’s innovation and market positioning contributed to its acquisition by Novartis.
How Howbridge Helped:
Howbridge worked closely with Kedalion Therapeutics leadership to help define the company’s market narrative, strengthen strategic communications, and position the organization for investor, partner, and industry engagement.
Together, we helped translate complex ophthalmic innovation into a clear commercialization story capable of supporting fundraising, market readiness, and strategic growth opportunities.
Key Growth Results:
Kedalion Therapeutics
The Challenge:
Position pioneering technology for strategic growth.
Kedalion Therapeutics was developing highly innovative ocular delivery technology with the potential to significantly improve the administration and patient experience of ophthalmic therapies.
While the underlying technology and science were compelling, leadership needed a clearer way to communicate both the commercial opportunity and the real-world patient impact of the AcuStream™ platform to investors, strategic partners, and the broader ophthalmics market.
The challenge was helping stakeholders quickly understand the significance of the technology while positioning the company for future commercialization and strategic acquisition opportunities.
Key Deliverables
Guided by our Core 4 Operating System™, we worked alongside leadership to address the organization's most pressing growth challenges. The following key deliverables were implemented across people, process, performance, and market engagement to improve efficiency, strengthen customer experience, and position the company for long-term success.
FOSTER A CULTURE
OF GROWTH
- Leadership Collaboration
- Strategic Growth Alignment
- Founder Vision Workshops
- Organizational Positioning Support
OPTIMIZE FINANCIAL
DRIVERS
- Investor Positioning
- Commercialization Planning
- Growth Strategy Support
- Market Opportunity Development
DRIVE HIGH-VALUE
ENGAGEMENT
- Investor Communications
- Website & Digital Messaging
- Market Awareness Materials
- Stakeholder Engagement Strategy
- Strategic Presentation Development
OWN YOUR
MARKET
- Brand Positioning
- Value Proposition Development
- Competitive Differentiation
- Innovation Narrative Development
- Market Messaging Framework
Key Initiatives (4)
Solution:
Align innovation, patient impact, and commercialization strategy.
Howbridge helped Kedalion Therapeutics bridge the gap between breakthrough ophthalmic innovation and scalable market positioning by aligning branding, communications, investor engagement, and commercialization strategy into a more unified growth platform.
By helping leadership better communicate both the clinical significance and future market potential of the AcuStream™ platform, Kedalion strengthened investor confidence, improved market visibility, and positioned the company for strategic growth.
That momentum ultimately contributed to Novartis acquiring Kedalion Therapeutics and its AcuStream™ technology to support future ophthalmic therapies and patient-centered innovation.
From the Client
“Howbridge helped us take highly complex innovation and communicate it in a way that investors and stakeholders could quickly understand.
Their strategic insight and execution helped position us for the next phase of growth.”
